Inspection Record

Apotex Pharmachem India Pvt. Ltd. — Health Canada Inspection Findings

Health CanadaInspected 2025-02-03 4 findingsEquipment and facilityContamination controlDeviation, CAPA, and investigation

View the regulator's official source The source document is always the basis for judgement.

Findings

1Equipment and facility

The design, construction, and/or location of the equipment did not allow adequate cleaning, sanitizing, and/or inspection of the equipment. The design, construction, operation, and/or location of the equipment was inadequate for preventing contamination of the drug. The usage logs for the equipment used for significant processing and/or testing operations were inadequate.

2Equipment and facility

The availability, content and/or maintenance of the quality agreements between the supplier, fabricator, tester, packager, labeller, distributor, importer, and/or wholesaler was inadequate.

3Contamination control

The sanitation programs were not adequately designed to identify and/or reduce the risks of contamination.

4Deviation, CAPA, and investigation

Investigations into deviations, reports, and/or follow-up actions were inadequate.

About this record

Extracted automatically from the document of the Health Canada inspection on 2025-02-03. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Apotex Pharmachem India Pvt. Ltd. company profile — full history Health Canada documents, 2025 Go to Findings search